Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública -ko ikertzaileekin lankidetzan egindako argitalpenak (39)

2024

  1. Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations

    Pathogens, Vol. 13, Núm. 8

  2. Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case–control study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 6

  3. Serological Outcome in the First Months of Life of Children Born to Mothers with SARS-CoV-2 Infection during Pregnancy

    Children, Vol. 11, Núm. 9

2022

  1. Correspondence on: 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort' by Pouletty et al

    Annals of the Rheumatic Diseases

  2. Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

    Emerging Infectious Diseases, Vol. 28, Núm. 11, pp. 2321-2325

  3. Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home

    Viruses, Vol. 14, Núm. 7

  4. Individual prevention and containment measures in schools in Catalonia, Spain, and community transmission of SARS-CoV-2 after school re-opening

    PLoS ONE, Vol. 17, Núm. 2 February

  5. Low transmission of SARS-CoV-2 derived from children in family clusters: An observational study of family households in the Barcelona Metropolitan Area, Spain

    PLoS ONE, Vol. 17, Núm. 11 November

  6. Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts

    Frontiers in Immunology, Vol. 13

  7. Safety and effectiveness of bubble continuous positive airway pressure as respiratory support for bronchiolitis in a pediatric ward

    European Journal of Pediatrics, Vol. 181, Núm. 12, pp. 4039-4047

2021

  1. How Did the COVID-19 Lockdown Affect Children and Adolescent's Well-Being: Spanish Parents, Children, and Adolescents Respond

    Frontiers in Public Health, Vol. 9

  2. Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations

    Journal of Infection

  3. Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 10, pp. 486-492

  4. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13

    Microbiology Spectrum, Vol. 9, Núm. 3

  5. Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain

    Clinical Infectious Diseases, Vol. 72, Núm. 12, pp. E970-E977

  6. The positive rhinovirus/enterovirus detection and sars-cov-2 persistence beyond the acute infection phase: An intra-household surveillance study

    Viruses, Vol. 13, Núm. 8

  7. Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples

    International Journal of Infectious Diseases, Vol. 110, pp. 363-370

2020

  1. Epidemiological, clinical, and microbiological characteristics of serotype-3 streptoccocus pneumoniae infection after a partial introduction of the 13-valent pneumococcal conjugate vaccine: A prospective observational study

    Journal of Pediatric Infectious Diseases, Vol. 15, Núm. 4, pp. 169-175

  2. Erratum for Hernández et al., "Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods"

    Journal of clinical microbiology

  3. Failures of 13-valent conjugated pneumococcal vaccine in age-appropriately vaccinated children 2-59 months of age, Spain

    Emerging Infectious Diseases, Vol. 26, Núm. 6, pp. 1147-1155